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these patients because the majority (>90%) presented with
swelling alone or in combination with other symptoms.
Sixty limbs among this group had abnormal nucleotide
scintigraphic appearance before stent placement, and the
rest were normal. Poststent nucleotide scintigraphy has
been completed after placement of venous stent in 28 of
these 60 limbs, 17 are scheduled to be tested at their 6-
month follow-up visit, 8 have declined for a variety of rea-
sons, 2 have moved, and 5 have been lost to follow-up.
Two of these 28 limbs had occluded stents; lym-
phoscintigraphy normalized in one after successful salvage
with a veno-venous bypass, and in the other patient, lym-
phoscintigraphy remains abnormal with an occluded stent.
Both of these patients were omitted from further analysis,
leaving 26 limbs for this study.
Clinical presentation. All 26 patients presented with
leg swelling, and 15 had associated pain. Swelling was
graded by physical examination as follows: grade 0, none;
grade 1, pitting, not obvious; grade 2, ankledema; grade
3, obvious swelling involving the limb (Table I). The level
of pain was measured by the visual analogue scale
method.1 A commonly available opaque tape measure or
ruler scale trimmed to 10-cm length is conveniently used
for this purpose. The patient was asked to indicate his pain
level on the unmarked or blank side of the device, with
one end representing no pain and the other, extreme pain.
Nucleotide lymphoscintigraphy has replaced contrast
lymphangiography for the diagnosis of lymphedema.
Absent or delayed nucleotide activity in femoral and pelvic
nodes in the presence of leg swelling is commonly inter-
preted as indicative of lymphedema. It was therefore of
interest to find that in several cases, nucleotide lym-
phoscintigraphy repeated after correction of a coexisting
iliac venous stenosis by stent deployment improved or
normalized. This suggests that abnormal lymphoscinti-
graphic appearance may, in some cases, represent an easily
correctable condition rather than refractory lymphedema.
MATERIAL AND METHODS
Three hundred sixty-seven limbs underwent stent
deployment for correction of iliac venous stenosis at River
Oaks Hospital between March 1997 and January 2001.
Nucleotide scintigraphy was a routine part of work up of
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associated venous obstruction
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Purpose: The purpose of this study was to report improvement or normalization of abnormal lymphoscintigraphy in
swollen lower limbs after correction of associated venous stenosis by balloon dilatation and placement of venous stent
of the iliac veins.
Material: Twenty-six patients with lower-limb swelling underwent balloon dilatation and placement of venous stent of the
iliac veins for correction of venous stenosis. Technetium 99M-sulfur colloid lymphoscintigraphy was also abnormal (8
absent, 18 reduced) before stent placement in all 26 limbs, suggesting combined venous/lymphatic etiology for the limb
swelling. Median age was 53 years. Male-to-female ratio was 1:8 and left-to-right ratio, 3:1. Fifteen patients had limb pain
associated with the swelling. Severity of venous stenosis was generally underestimated by preoperative transfemoral venog-
raphy as compared with intravascular ultrasound, (mean, 50% versus 77%); in five limbs (19%), transfemoral venography
altogether failed to identify the venous lesion evident on intravascular ultrasound. The etiology of venous obstruction was
post-thrombotic in nine limbs and nonthrombotic (web, stricture, or May-Thurner syndrome) in 17 limbs.
Results: Poststent lymphoscintigraphy completely normalized in 10 limbs, improved but remained abnormal in 9, and
remained unchanged in 7. Clinical follow-up (mean, 1 year) showed improvement in swelling in 16 of 26 limbs (P <
.022), with complete resolution of swelling in six; degree of pain also improved (P < .02), with total relief of pain in
9 of 15 patients. There was also significant improvement in all categories of a quality of life questionnaire.
Conclusion: These findings suggest that patients with a diagnosis of lymphedema made on the basis of lymphoscintig-
raphy alone and consigned to conservative therapy on that basis may benefit from additional venous investigations
regardless of clinical presentation suggestive of lymphedema. This report supports the practice of aggressively search-
ing for a venous basis of edema in these patients. Correction of the venous lesion may result in normalization or
improvement of the lymphoscintigraphic abnormality and in any case may yield significant symptom relief, even in some
limbs where the lymphoscintigraphic abnormality failed to improve after placement of venous stent. (J Vasc Surg
2001;34:779-84.)
The indicated pain level was then translated into numeric
grade (0-10) by the examiner by referring to the scale
markings on the other side hidden to the patient. Patients
were asked to fill out a quality of life questionnaire vali-
dated for assessment of chronic venous insufficiency2
prospectively before stent placement and again about 1
year (median) after the stent. Numerical grades (1-5) were
provided for each question, allowing the patient to assign
a numeric value to the answers.
Preoperative work up. All patients underwent nucleo-
tide lymphoscintigraphy, complete duplex venous scan,
venous functional studies (Table II), and transfemoral
venography.
Nucleotide lymphoscintigraphy. Technetium 99M-
sulfur colloid was injected intradermally and subcuta-
neously into the first web space and images of the lower
limb and pelvis acquired with a gamma camera at 5, 10, 20,
30, and 60 minutes. Patients were asked to walk before the
injection and between the images. The temporal progres-
sion of activity up the limb and the appearance of isotope
activity in the inguinal and pelvic nodes at these time inter-
vals3 were the basis for interpreting abnormal lymph activ-
ity. Other abnormalities of local lymph flow, such as
pooling, were also recorded. The images were interpreted
as normal when rapid flow progressed up the limb sym-
metrically with the opposite limb and nodes were rapidly
visualized. When normal, nodal activity was visible as early
as 10 minutes and well developed by 20 minutes. When
nodal visualization was faint or delayed beyond 30 min-
utes, lymphatic activity was considered abnormal and
reduced. When nodal visualization failed to occur at 60
minutes, lymphatic activity was interpreted as being absent.
The lymphoscintigraphic data were collected from con-
temporaneous reports by the interpreting radiologist not
involved in the study.
Placement of venous stent. Placement of the
venous stent was performed for clinical symptoms in
patients refractory or intolerant to conservative therapy.
Details of patient selection and stent placement tech-
nique have been described in full elsewhere.4,5 Because
the sensitivity of transfemoral venography to identify sig-
nificant iliac vein stenoses was poor,4,5 intravascular
ultrasound (IVUS) was used liberally to identify treatable
lesions. After balloon dilatation, placement of venous
stent was mandatory because recoil of the dilated steno-
sis otherwise occurred.4,5 The procedure was carried out
percutaneously on a 23-hour admission basis. Patients in
this series were placed on once-a-day aspirin (81 mg)
after the procedure. New generation antiplatelet agents
were not used.
Follow up. Patients were seen 6 weeks after place-
ment of the stent for clinical evaluation and transfemoral
venography to assess patency of the stent. Thereafter
patients were seen at 4 to 6 monthly intervals for follow-
up clinical examination. Postoperative nucleotide lymph-
angiography was performed at about 6 months (median)
after the placement of venous stent.
Data collection and statistics. All clinical (including
severity scores), venographic, and lymphoscintigraphic
data were contemporaneously entered at each patient visit
into a time-stamped electronic medical record database
and analyzed later for this manuscript. The nonparametric
Wilcoxon signed rank test was used to compare preopera-
tive and postoperative values.
RESULTS
The mean follow-up period was 1 year (median, 9
months; range, 2-35 months).
The median age of the 26 patients was 53 years
(range, 15-75 years), the male-to-female ratio was 1:8 and
the left-to-right ratio was 3:1. The venous stenosis
involved the inferior vena cava and the common iliac vein
in 2 patients, the common iliac vein alone in 16, both the
common and external iliac veins in 6, and the iliac veins
and the common femoral vein in 2. The venous lesion was
considered nonthrombotic (web, stricture, or May-
Thurner syndrome) in 17; a post-thrombotic etiology was
apparent on venography and/or IVUS examination in
nine limbs. The percentage stenosis of the lesion estimated
on venography was much less than direct intraoperative
measurement by IVUS (median stenosis, 50% versus 77%);
in five limbs there was no venographic stenosis at all
(occult venographic stenosis); the stenotic lesion was
solely detected by IVUS (Fig 1). Collaterals were identi-
fied by the authors prospectively in 24 out of 26 cases on
examining prestent transfemoral venograms; in many
instances, the observed collaterals were small, faint (pre-
sacral), or only partially visualized (ascending lumbar or
axial) precluding easy detection. The presence of collater-
als was reported quite infrequently by the radiologist
interpreting the same films and only when they were large
and prominent. This difference is probably a result of
observer bias.
Clinical outcome. The degree of swelling decreased
significantly after placement of venous stent from a
median preoperative grade of 3 (range, 1-3) to grade 2
(range, 0-3) (P < .022). In 6 out of 26 limbs, swelling
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Fig 1. Normal-appearing preoperative transfemoral venogram
(left) in a patient who had a web stricture detected by IVUS
(right). The residual lumen at the stricture site is barely larger
than the IVUS catheter (8 French). Adjoining luminal structure
indicated by a is artery.
totally disappeared after placement of venous stent (Table
I). Notably, 6 out of 26 limbs with massive preoperative
swelling had total (grade 0) or near total (grade 1) disap-
pearance of swelling after placement of venous stent.
Improvement in swelling by one grade or more over the
prestent level occurred in 16 out of 26 (62%) limbs, with
10 limbs showing no objective change in limb swelling. In
no patient did the swelling get worse after the placement
of venous stent. Two patients who had recurrent episodes
of cellulitis prestent have remained free of this complica-
tion during the follow-up period.
The degree of pain also significantly decreased from a
median prestent level of 5 (range, 1 to 8) to <1 (range, 0
to 6) poststent (P < .02). In 9 out of 15 patients with pre-
operative pain, there was total relief of pain after place-
ment of venous stent.
Quality of life. After stent placement, patients had
improved quality of life in all major categories addressed in
the questionnaire (subjective pain, sleep disturbance,
morale and social activities, and routine and strenuous phys-
ical activities) (P < .048 or better for each category). No
improvement in any of the quality of life criteria occurred
among the patients (n-10) without clinical improvement.
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Nucleotide lymphoscintigraphy. All of the 26 limbs
obviously had either absent or reduced activity before
stent placement (Table III). After placement of the stent,
retesting showed either normalization (10 limbs) or
improvement (nine limbs) in 19 out of 26 limbs (73%); no
change was noted in seven limbs.
Clinical correlation. Clinical improvement in
swelling was accompanied by either normalization or
improvement in lymphoscintigraphic appearance in most
cases (14/16, 88%); in two (12%) limbs with clinical
improvement in swelling, lymphoscintigraphy was subnor-
mal before the stent procedure and unchanged afterwards.
Curiously, in 5 out of 10 limbs with no improvement in
limb swelling after the stent procedure, lymphoscintigra-
phy either normalized (2 limbs) or improved (3 limbs).
Fig 2 shows transfemoral venograms and nucleotide lym-
phoscintigraphy before and after placement of stent in a
case included in this series.
Venous function studies.4,5 Prestent and poststent
data for arm and foot venous pressure differential, ambu-
latory venous pressure, and air-plethysmography are
shown in Table II. Ambulatory venous pressure percent-
age drop improved significantly (P < .05); most other
Table I. Limb swelling before and after placement of venous stent
Prestent swelling grade* Poststent swelling grade n (limbs) Poststent lymphoscintigraphy†
3 (n = 17 limbs) 3 7‡ 3 improved,§ 4 unchanged
2 4 2 normalized, 2 improved
1 5 3 improved, 2 unchanged||
0 1 1 normalized
2 (n = 6 limbs) 2 3‡ 2 normalized,§ 1 unchanged
1 1 1 normalized
0 2 1 normalized, 1 improved
1 (n = 3 limbs) 0 3 3 normalized
*Grade 0 = none; grade 1 = pitting; grade 2 = ankledema; grade 3 = gross.
†Normalized, normal poststent lymphoscintigram compared with subnormal or absent activity prestent; improved, poststent lymphatic activity was subnor-
mal but considered improved because none existed before or there was less delay and better visualization compared to lymphatic activity prestent;
unchanged, poststent lymphatic activity was either subnormal or altogether absent, identical to the prestent status.
‡Swelling unchanged after placement of venous stent. There is a total of 10 limbs (7 with grade 3 and 3 with grade 2) in this category.
§Lymohoscintigraphic improvement without clinical improvement in limb swelling. There is a total of 5 limbs (3 with grade-3 and 2 with grade-2 swelling
prestent) in this category.
||Improvement in limb swelling without lymphoscintigraphic improvement. There is a total of 2 limbs in this category (both with grade-3 swelling
prestent improving to grade 1 poststent).
Table II. Venous functional studies4,5,10 before and after stent placement*
Test n Prestent (mean ± SD) Poststent (mean ± SD) P
Arm/foot pressure differential 15 1.9 ± 1.6 1.3 ± 1.8 NS
Reactive hyperemia pressure increase 15 6.5 ± 5.6 4.1 ± 3.0 NS
Obstruction grade 15 1.5 ± 1 1.2 ± 0.7 NS
Ambulatory pressure drop (%) 14 45 ± 11 40 ± 9 <.05
Ambulatory pressure recovery time (s) 14 38 ± 30 21 ± 11 NS
APG venous volume (mL) 18 58 ± 28 52 ± 26 NS
APG ejection fraction (%) 18 58 ± 21 67 ± 19 NS
APG residual volume fraction (%) 18 38 ± 23 30 ± 17 NS
*Three patients had significant(>100 mL/min) deep reflux at one or more valve sites before stent placement; swelling improved in two and remains
unchanged in one after stent placement.
NS, Not significant; APG, airplethysmography.
parameters improved, although not significantly in this
small sample size.
Data were separately analyzed for three subsets of
patients with clinical features of limb swelling considered
highly suggestive of lymphedema (bilaterality, preadoles-
cent onset, swelling of >10-year duration). Both clinical
and lymphoscintigraphic improvement occurred in all
three subsets (Table III).
DISCUSSION
Lymphedema is generally classified as “primary”
because of a congenital or developmental abnormality in
the lymphatic system or “secondary” because of destruc-
tion of lymph nodes and conduits through disease, surgi-
cal ablation, or other causes. Kinmonth6 classified primary
lymphedema into several categories on the basis of lymph-
angiographic studies with contrast. The advent of isotope
lymphoscintigraphy has effectively displaced this cumber-
some and technically demanding open technique. Witte7
has recently reviewed the development of nucleotide lym-
phoscintigraphy, its clinical use, and current “state of the
art,” along with his considerable experience with this diag-
nostic modality. Technetium 99M-sulfur colloid is widely
used as in this study and emphasizes nodal activity.
Technetium 99m–labeled human serum albumin injected
intradermally tends to emphasize lymph channels, but
nodal activity may be less.7 Villavicencio3 has detailed the
various lymphoscintigraphic abnormalities found in lym-
phedema and in venous pathology.3,8 Twenty to thirty
percent of patients with confirmed venous stasis have been
reported to show an abnormal nucleotide lymphoscintig-
raphy as well in several series.9,10 One theory ascribes this
association to abnormal lymph transport resulting from
destruction of local lymphatics by edema and other tissue
changes induced by venous stasis. We speculate that the
edema of venous origin and the resulting increased load
on the lymphatics in some fashion leads to a spurious lym-
phoscintigraphic appearance even when no inherent
abnormality of the lymphatic system exists. In some
patients, true overload decompensation of the lymphatic
system may occur with onset of venous obstruction. Any
pre-existing subclinical lymphatic abnormality will likely
be predisposed to overload induced failure. Relief of
venous obstruction may allow recovery of the lymph
transport mechanism. Lymphatic function appears to
improve also after venous valve reconstruction for correc-
tion of reflux (6 limbs, unpublished data). Regardless of
the precise mechanism, it is clear that the nucleotide lym-
phoscintigraphic test may improve and even revert to nor-
mal after the venous stenosis is relieved. The reason for the
absence of clinical improvement in swelling in 5 out of 10
limbs that showed improvement in lymphoscintigraphy is
unclear. This may be because of a time factor, coexisting
significant reflux (1/5) (Table II), or the dominance of
lymphatic pathology over the venous obstruction. No pre-
operative predictors of poor clinical outcome were found
in the 10 patients who did not improve their swelling.
Based on this report and our previous experience,4,5
some recommendations can be made on the work-up of
patients presenting with symptomatic limb swelling in
whom systemic causes have been excluded. Lympho-
scintigraphy and venous studies are a routine part of work-
up in most such patients, particularly in those under
consideration for intervention or surgery at our institu-
tion. In our practice, the etiology of limb swelling on
complete work-up is found to be venous alone in about
75% of limbs, venous and lymphatic in about 20%, and
lymphatic alone in about 5%. During the period covered
by this study, a total of 74 symptomatic limbs were found
to have abnormal lymphoscintigraphy; 60 limbs were
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Fig 2. Preoperative and postoperative transfemoral venograms.
A, correction of iliac venous stenosis by a long 16-mm stent. B,
normalization (right panel) of previously absent (left panel)
lymphoscintigraphic nodal activity after stent placement.
A
B
found to have associated venous stenosis and are included
in this series. In the remaining 14 limbs, venous outflow
obstruction was ruled out and the pathology is presumed
to be purely lymphatic. Among limbs that underwent
venous stent placement, swelling was the primary com-
plaint in 53%, and it was present in association with other
symptoms in 96%.5 Despite assertions to the contrary in
many clinical texts, it has been our experience that there is
no clinical feature or sign that can reliably differentiate
lymphedema from swelling of venous or combined venous
and lymphatic origin (Table III). When a venous lesion has
been definitively excluded, an abnormal lymphoscintigram
provides confirmation of the diagnosis of lymphedema 
and assigns prognosis. An abnormal lymphoscintigram
obtained preoperatively, before an associated venous
lesion is corrected, allows cautionary counseling to the
patient regarding outcome possibilities. A normal lym-
phoscintigram obtained before the correction of a venous
lesion provides reassurance to the patient (and the sur-
geon) that postoperative exacerbation of limb swelling
that occurs in some patients is likely to be transient.
Ascending venography is inadequate for investigation of
the iliac venous segment because of poor contrast visual-
ization. Transfemoral venography is the mainstay in most
institutions for this purpose. A venous stenosis will be sus-
pected in about half of the cases based on this investiga-
tion. It is recommended that the vascular surgeon
personally examine the films. Because of the lack of gen-
eral awareness of the significance of these lesions, radiolo-
gists often limit their report to patency (“the iliac veins are
patent”) without reference to diffuse or focal lesions that
may be present. Noncollateralizing diffuse stenoses occur
in the iliac veins and are easily missed.4 Besides these
interpretational problems, transfemoral venography is
technically limited in identifying iliac vein stenoses because
the luminal compromise is disproportionately in the ante-
rior posterior plane11 appearing as thinning out of contrast
and even broadening of the lumen at the lesion site rather
than the familiar constriction; webs, membranes, and stric-
tures of short length are common in this location and are
easily masked by the density of contrast leading to a spuri-
ously normal venographic appearance (Fig 1). There were
five (19%) such venographically occult stenoses in this
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series, which parallels our previous experience.4,5,11 IVUS
does not have these shortcomings11; it is a percutaneous
procedure and is easily followed by stent placement if indi-
cated at the same sitting. We have increasingly come to
rely on IVUS to investigate and treat iliac vein stenoses.11
However, transfemoral venography is adequate for assess-
ing gross patency of venous stents.5
Most often, lymphoscintigraphy is the only investiga-
tion, if any is performed, that is obtained in suspected
cases of lymphedema because of its ease and ready avail-
ability. Unfortunately, if the lymphoscintigram is abnor-
mal, a confirmed diagnosis of lymphedema is made and
the patient is assigned to lifelong conservative measures
with little prospect of definitive therapy. This report sup-
ports the practice of aggressively searching for a venous
basis of edema in these patients. If it is found and cor-
rected, significant clinical improvement in limb swelling
and pain occurs in many patients, even in some patients in
whom postoperative nucleotide lymphoscintigram fails to
improve or normalize. Many patients reported relief of
pain as contributing significantly to an improved quality
of life, even when swelling was not completely relieved.
Most patients presenting with pain in this series had sig-
nificant pain relief after placement of stent. Traditional
teaching states that true lymphedema is often painless.
The presence of pain is perhaps an indication of an under-
lying venous stenosis despite an abnormal lymphoscinti-
gram. The relative safety and ease with which iliac venous
stenoses can be corrected by placement of a venous stent
only emphasizes the fact that venous stenoses should be
looked for aggressively in this group of patients regardless
of an abnormal lymphoscintigram. We have similar expe-
rience in two patients (not included in this series) who
carried the diagnosis of postmastectomy lymphedema,
only to have the edema relieved when coincident venous
stenoses were corrected; the etiology of the lesions were
probably surgical trauma and/or radiation.
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Dr Thomas W. Rooke (Rochester, Minn). This is a topic that
has intrigued me for over a decade. In 1991, I attended a confer-
ence at Mayo Clinic involving a patient who had chronic thrombo-
sis in the iliac vein, severe swelling and ulceration of the leg, and an
abnormal lymphoscintigram. The patient underwent an operation
to restore venous flow, and his leg swelling and symptoms subse-
quently improved. I remember wondering to myself whether the
lymphatic abnormalities changed as the result of surgery.
Unfortunately, a follow-up lymphoscintigram was not
obtained, so I never knew whether the lymphatic drainage had also
improved.
Since that time, practitioners on both sides of the Atlantic have
described a relationship between abnormal lymphoscintigraphy and
chronic venous disease. Even our own Dr Gloviczki—who has his
fingers in just about everything—has reported an association
between venous obstruction and lymphatic obstruction, but until
now no one has shown that lymph flow can improve if the venous
obstruction is relieved.
I will ask three questions about this presentation.
I am bothered by the discrepancy between venography and
IVUS. In particular, it is unsettling that 5 patients out of 26 had
completely normal findings on venography, and that one patient
with a normal venogram actually had a 90% narrowing by IVUS.
That does not jibe with my clinical experience. Perhaps IVUS over-
estimates the degree of stenosis—do we have any information on
the pressure gradients (across the stenosis) in these patients? Or is it
possible that IVUS causes catheter-associated vasospasm which sim-
ulates severe stenosis?
My second question involves adjunctive therapy for venous dis-
ease and limb swelling. After venous stents were placed, I assume
that some other treatment for swelling was provided—perhaps elas-
tic compression was applied, or perhaps drug therapy with diuretics
was initiated? If so, these treatments—rather than venous revascu-
larization—may have produced some (or all) of the improvement in
lymph flow? Perhaps the authors have seen patients who presented
with symptomatic venous obstruction associated with abnormal
lymphoscintigraphy, but who did not undergo venous revascular-
ization; that is, patients who were simply treated with conservative
measures for their venous obstruction and edema? If so, did conser-
vative treatment alone eventually lead to clinical improvement? Do
we know what happens to their lymphoscintigrams? Do they also
improve? It seems possible that the improvement in lymph flow
observed in this study following venous revascularization may have
been due to the associated treatments (such as elastic compression
or drugs) rather than the venous revascularization?
Finally, I was intrigued that no lymphoscintigrams worsened
after stenting. That is surprising, because I assume that stenting will
relieve the venous hypertension in these patients; in the face of
“fixed” lymphatic obstruction, the drop in venous pressure should
decrease Starling forces and lead to an immediate decrease in lym-
phatic flow. We did not see this, perhaps because the lymphoscinti-
grams were so abnormal to begin with. Eight of them had absent
flow; they really could not worsen after venous revascularization. I
wonder if the authors could just comment on this?
I enjoyed the paper very much. Thank you.
Dr Seshadri Raju. Thank you, Dr Rooke, for those comments. 
I do not think venous spasm is a factor in the discrepancy
between venography and IVUS. We routinely perform a venogram
either before or after IVUS on the table in the endovascular room.
There is no spasm on the intraoperative venogram which pretty
much looks like the preoperative venogram. I think there are three
factors why the venogram can be deceptively normal. First, the
stenosis is often in the anterior posterior plane as already mentioned
in the previous paper by Dr Neglen, and it does not show up well
on single-plane films. Second, there is considerable dilution of the
contrast, even on transfemoral venograms, by the large hypogastric
flow, and the iliac vena caval junction often becomes fuzzy because
of this dilution. And most importantly, many of the lesions in this
area are truly web-like or membranous-like and are easily masked by
contrast (or lack of it).
In a handful of cases, even IVUS failed to pick up a membra-
nous short stenosis and we knew the stenosis was there only because
tight waisting was observed on balloon dilatation.
We do not know why the lymphoscintigram improves after
stenting. We do have similar experience with six cases of valve recon-
structions.
We are not big fans of lifelong compression therapy. We do
surgery so that patients may discard the stocking. We recommend
that they wear them as they please. About half of them will discard
it. The other half will use it intermittently.
We think a minority of these cases are true lymphedema and
the venous stenosis is incidental. These are the cases that do not
improve after stenting. In the majority of the cases, the pathology
is primarily venous and the abnormal lymphogram is a secondary
phenomenon and reversible in our opinion. We speculate there are
probably several reasons why the lymphogram becomes abnormal
in the presence of a significant venous stenosis. We think the main
reason is technical. Because of the Starling forces, there is a large
interstitial fluid compartment that simply dilutes the isotope
beyond visibility. It would be interesting to give these patients
double or triple the usual dose of isotope and see if the lymphat-
ics visualize. Another possibility is that the lymphatics lose their
tone and become paralyzed because of overload. I heard Dr
Moneta suggest in one of the meetings earlier this year that local
lymphatics may become damaged by the tissue edema of venous
stasis. We know from organ transplant experience that lymphatics
have a tremendous capacity to regenerate. Once the venous cause
is removed, they may regenerate again. We do not know.
Thank you.
DISCUSSION
